Assiguxanthone B exhibits significant potential in pharmaceutical applications due to its bioactive properties. It has demonstrated antimicrobial and cytotoxic activities, making it a candidate for drug development, particularly in targeting infectious diseases and certain cancer cell lines. Research suggests it may interfere with cellular proliferation pathways, supporting its investigation as a lead compound in oncology. Additionally, its structural features are of interest in the design of novel therapeutic agents, especially in natural product-based drug discovery. Studies are ongoing to evaluate its efficacy, safety, and mechanisms of action in biological systems.